AxoGen, Inc.
AxoGen, Inc. logo
AXGN

AxoGen, Inc. (AXGN)

$10.954.48%

Market is closed
– opens on 8 PM, 01 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$10.36
Day's Range
$11.07
$6.87
52-Week Range
$13.66
1 month return1.97%
3 month return16.74%
1 year return16.12%
5 year return58.52%

Company Information

Axogen (AXGN) is the leading company focused specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. Axogen employees are passionate about helping to restore peripheral nerve function and quality of life to patients with physical damage or transection to peripheral nerves by providing innovative, clinically proven, and economically effective repair solutions for surgeons and health care providers. Peripheral nerves provide the pathways for both motor and sensory signals throughout the body. Every day, people suffer traumatic injuries or undergo surgical procedures that impact the function of their peripheral nerves. Physical damage to a peripheral nerve, or the inability to properly reconnect peripheral nerves, can result in the loss of muscle or organ function, the loss of sensory feeling, or the initiation of pain.
OrganizationAxoGen, Inc.
Employees428
CEOMs. Karen Zaderej
IndustryHealth Technology

Analyst Recommendation

based on 7 analysts ratings

Buy
71%
Buy
28%
Hold
0%
Sell

Based on 7 Wall street analysts offering stock ratings for AxoGen, Inc.(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 61.37%

Current

$10.95

Target

$17.67

Recommendation Trend

Based on 7 analyst

Current1M Ago3M Ago
Buy
5
11
11
Hold
2
2
2
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
443.2M
Book Value
$2.4
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-0.77
PEG Ratio
0.0
Wall Street Target Price
17.67

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
4.66
Enterprise Value
487.3M
Enterprise Value/Revenue
3.64
Enterprise Value/Ebitda
-20.8

Technicals

Beta
0.54
50 Day MA
11.44
200 Day MA
9.58

Institutional Holdings

ArrowMark Colorado Holdings, LLC (ArrowMark Partners)

11.46%

First Light Asset Management, LLC

6.89%

Point72 Asset Management, L.P.

4.93%

Vanguard Group Inc

4.51%

Bank of America Corp

4.13%

William Blair Investment Management, LLC

3.44%

Discover more

Frequently Asked Questions

What is AxoGen, Inc. share price today?

Can Indians buy AxoGen, Inc. shares?

How can I buy AxoGen, Inc. shares from India?

Can Fractional shares of AxoGen, Inc. be purchased?

What are the documents required to start investing in AxoGen, Inc. stocks?

What are today’s High and Low prices of AxoGen, Inc.?

What are today’s traded volumes of AxoGen, Inc.?

What is today’s market capitalisation of AxoGen, Inc.?

What is the 52 Week High and Low Range of AxoGen, Inc.?

How much percentage AxoGen, Inc. is down from its 52 Week High?

How much percentage AxoGen, Inc. is up from its 52 Week low?

What are the historical returns of AxoGen, Inc.?

Who is the Chief Executive Officer (CEO) of AxoGen, Inc.?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*